Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain

被引:59
作者
Su, JH [1 ]
Kesslak, JP [1 ]
Head, E [1 ]
Cotman, CW [1 ]
机构
[1] Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA
关键词
granulovacuolar degeneration; activated caspase-3; caspase-cleaved amyloid precursor protein; Alzheimer's disease; Down's syndrome;
D O I
10.1007/s00401-002-0548-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Granulovacuolar degeneration (GVD) is a diagnostic neuropathological feature of Alzheimer's disease (AD). In some neurons, apoptosis has been hypothesized to be a primary mechanism causing neuronal cell death in AD. In this study we investigated CA1 neurons with GVD in AD and Down's syndrome (DS) brain. We demonstrated that activated caspase-3 and a caspase-cleaved cleavage product of the amyloid precursor protein (cAPP) are co-localized in GVD granules, and that these same cells often show nuclear DNA damage. In contrast, activated caspase-8 is present in the cytoplasm but not within the granules of GVD neurons. A caspase-cleavage product of fodrin that accumulates in many AD and DS neurons is not present in GVD granules. These data support a role for the activation of apoptotic mechanisms in selective compartments exhibiting GVD.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 21 条
[1]  
ADAMS JH, 1992, GREENFIELDS NEUROPAT, P1312
[2]   ASSOCIATION OF THE CARBOXY-TERMINUS OF BETA-AMYLOID PROTEIN-PRECURSOR WITH ALZHEIMER PAIRED HELICAL FILAMENTS [J].
CAPUTO, CB ;
SOBEL, IRE ;
SCOTT, CW ;
BRUNNER, WF ;
BARTH, PT ;
BLOWERS, DP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 185 (03) :1034-1040
[3]   Apoptosis decision cascades and neuronal degeneration in Alzheimer's disease [J].
Cotman, CW .
NEUROBIOLOGY OF AGING, 1998, 19 (01) :S29-S32
[4]   Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-β precursor protein and amyloidogenic Aβ peptide formation [J].
Gervais, FG ;
Xu, DG ;
Robertson, GS ;
Vaillancourt, JP ;
Zhu, YX ;
Huang, JQ ;
LeBlanc, A ;
Smith, D ;
Rigby, M ;
Shearman, MS ;
Clarke, FE ;
Zheng, H ;
Van Der Ploeg, LHT ;
Ruffolo, SC ;
Thornberry, NA ;
Xanthoudakis, S ;
Zamboni, RJ ;
Roy, S ;
Nicholson, DW .
CELL, 1999, 97 (03) :395-406
[5]   Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease [J].
Hartmann, A ;
Hunot, S ;
Michel, PP ;
Muriel, MP ;
Vyas, S ;
Faucheux, BA ;
Mouatt-Prigent, A ;
Turmel, H ;
Srinivasan, A ;
Ruberg, M ;
Evan, GI ;
Agid, Y ;
Hirsch, EC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2875-2880
[6]  
Lee JP, 2000, J NEUROSCI RES, V60, P565, DOI 10.1002/(SICI)1097-4547(20000515)60:4<565::AID-JNR16>3.0.CO
[7]  
2-I
[8]   A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor [J].
Lu, DC ;
Rabizadeh, S ;
Chandra, S ;
Shayya, RF ;
Ellerby, LM ;
Ye, X ;
Salvesen, GS ;
Koo, EH ;
Bredesen, DE .
NATURE MEDICINE, 2000, 6 (04) :397-404
[9]   Recent advances on neuronal caspases in development and neurodegeneration [J].
Marks, N ;
Berg, MJ .
NEUROCHEMISTRY INTERNATIONAL, 1999, 35 (03) :195-220
[10]   Apoptosis - Caspases find a new place to hide [J].
Mehmet, H .
NATURE, 2000, 403 (6765) :29-30